BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17312826)

  • 1. Validation of a point of care lipid analyser using a hospital based reference laboratory.
    Carey M; Markham C; Gaffney P; Boran C; Maher V
    Ir J Med Sci; 2006; 175(4):30-5. PubMed ID: 17312826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments.
    Dale RA; Jensen LH; Krantz MJ
    Ann Pharmacother; 2008 May; 42(5):633-9. PubMed ID: 18413684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance of two point-of-care analysers for lipid testing.
    Shephard MD; Mazzachi BC; Shephard AK
    Clin Lab; 2007; 53(9-12):561-6. PubMed ID: 18257461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids].
    Ose L; Aass B; Christophersen B
    Tidsskr Nor Laegeforen; 1995 Nov; 115(28):3487-9. PubMed ID: 7491599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of two point of care devices for capillary lipid screening in fasting and postprandial adults.
    Donato LJ; Deobald GR; Wockenfus AM; Hornseth JM; Saenger AK; Karon BS
    Clin Biochem; 2015 Feb; 48(3):174-6. PubMed ID: 25448034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities.
    Shemesh T; Rowley KG; Shephard M; Piers LS; O'Dea K
    Clin Chim Acta; 2006 May; 367(1-2):69-76. PubMed ID: 16388790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Precision and accuracy of blood lipid analyses by a portable device (Cholestech-LDX)].
    Issa JS; Strunz C; Giannini SD; Forti N; Diament J
    Arq Bras Cardiol; 1996 Jun; 66(6):339-42. PubMed ID: 9035449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of lipid profile measurements obtained from the Cholestech L.D.X analyzer.
    Bard RL; Kaminsky LA; Whaley MH; Zajakowski S
    J Cardiopulm Rehabil; 1997; 17(6):413-8. PubMed ID: 9421763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Accuracy of 2 Point-of-Care Lipid Testing Devices.
    Bastianelli K; Ledin S; Chen J
    J Pharm Pract; 2017 Oct; 30(5):490-497. PubMed ID: 27313238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy and precision of the Cholestech LDX System in monitoring blood lipid levels.
    Santee J
    Am J Health Syst Pharm; 2002 Sep; 59(18):1774-9. PubMed ID: 12298117
    [No Abstract]   [Full Text] [Related]  

  • 11. A combined laboratory and field evaluation of the Cholestech LDX and CardioChek PA point-of-care testing lipid and glucose analysers.
    Whitehead SJ; Ford C; Gama R
    Ann Clin Biochem; 2014 Jan; 51(Pt 1):54-67. PubMed ID: 23880620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids.
    Panz VR; Raal FJ; Paiker J; Immelman R; Miles H
    Cardiovasc J S Afr; 2005; 16(2):112-7. PubMed ID: 15915279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving CardioCheck PA analytical performance: three-year study.
    Matteucci E; Della Bartola L; Rossi L; Pellegrini G; Giampietro O
    Clin Chem Lab Med; 2014 Sep; 52(9):1291-6. PubMed ID: 24695039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inaccuracy of lipid measurements with the portable Cholestech L.D.X analyzer in patients with hypercholesterolemia.
    Stein JH; Carlsson CM; Papcke-Benson K; Einerson JA; McBride PE; Wiebe DA
    Clin Chem; 2002 Feb; 48(2):284-90. PubMed ID: 11805009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point of care testing is appropriate for National Health Service health check.
    Jain A; Persaud JW; Rao N; Harvey D; Robertson L; Nirmal L; Nirmal D; Thomas M; Mikhailidis DP; Nair DR
    Ann Clin Biochem; 2011 Mar; 48(Pt 2):159-65. PubMed ID: 21355015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the point of care Afinion AS100 analyser in a community setting.
    Jain A; Rao N; Sharifi M; Bhatt N; Patel P; Nirmal D; Persaud JW; Nair DR
    Ann Clin Biochem; 2017 May; 54(3):331-341. PubMed ID: 27422136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Accutrend Plus point-of-care triglyceride analyzer in horses, ponies, and donkeys.
    Pongratz MC; Junge HK; Riond B; Schwarzwald CC
    J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):682-90. PubMed ID: 27508527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Non-Fasting Lipid Profile for the Assessment of Lipoprotein Coronary Risk.
    Fatima S; Ijaz A; Sharif TB; Khan DA; Siddique A
    J Coll Physicians Surg Pak; 2016 Dec; 26(12):954-957. PubMed ID: 28043305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous point-of-care testing of blood lipid profile and glucose: Performance evaluation of the GCare Lipid Analyzer.
    Kim HN; Yoon SY
    J Clin Lab Anal; 2021 Dec; 35(12):e24055. PubMed ID: 34697832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment.
    Whitehead SJ; Ford C; Gama R
    J Clin Pathol; 2014 Jun; 67(6):535-9. PubMed ID: 24711512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.